Ethnicity, age and incidence rates for renal replacement therapy (RRT) in Birmingham, UK:
|
|
- Brendan Norman
- 5 years ago
- Views:
Transcription
1 Nephrol Dial Transplant (28) 23: doi: 1.193/ndt/gfn366 Advance Access publication 2 July 28 Original Article Ethnicity, age and incidence rates for renal replacement therapy (RRT) in Birmingham, UK: Mark Lambie 1, Nick Richards 2 and Steve Smith 3 1 Renal Unit, Walsgrave Hospital, 2 Fresenius Medical Care and 3 Department of Renal Medicine, Birmingham Heartlands Hospital, UK Abstract Background. Birmingham is a densely populated, industrial city with a high social deprivation index and large black (B) and Indo-Asian (I) populations. End stage renal failure is known to be more common in ethnic minorities and urban communities. Workforce planning requires accurate epidemiological data but most studies of the effect of ethnicity in the UK are from the early 199s. Methods. RRT acceptance rates for adults (>16 years) in Birmingham were calculated for the 5-year periods and using the 1991 and 21 UK population census datasets and local programmes data. Results. The adult population of Birmingham Health Authority increased slightly (961,41 in 1991 v 977,99 in 21) but the proportion of W fell (82.7% to 74.3%) while B (5.3% to 7.%) and I (1.4% to 17.2%) both increased. Median age was lower for I ( , ) than B ( , ) and W ( , ). Numbers of new patients increased by 29% in W, 98% in B and 19% in I. There was also a substantial increase in acceptance rates (W 92 to 129 pmp, I 175 to 243 pmp, B 191 to 278 pmp) but the proportional increase in I (26.9%) was less than in W (41.5%) or B (48.2%). This is because almost all the increase in RRT acceptance rates for all ethnic groups was seen in the over 55 age group (256 pmp 1991, 481 pmp 21) but 85% of the population growth for I was in the under 55 age group. In all ethnic groups there was a striking increase in acceptance rates for the over 7 s (W 177 to 44 pmp, I 536 to 1711 pmp, B 31 to 1858 pmp). Conclusions. All acceptance rates were equivalent to the highest previously described in the UK. This may be due to local factors including social deprivation, availability of care and physicians attitudes. The increase in patient numbers was due to rising ethnic minority populations and increasing acceptance rates, especially in the elderly. The take-on rate is likely to rise disproportionately for I as the population ages over the next 1 years. This indicates that the future need for RRT in UK inner city areas, especially Correspondence and offprint requests to: Dr. Mark Lambie, Renal Unit, University Hospital, Coventry. United Kingdom. CV2 2DX. Tel: ; Fax: ; lambiem@doctors.org.uk those with a large elderly ethnic population, will be greater than previously estimated. Keywords: end-stage renal disease; ethnicity; incidence Introduction The incidence of end-stage renal failure (ESRF) patients accepted onto renal replacement therapy (RRT) has been shown to vary with ethnicity (higher in Indo-Asians and Blacks), age (increasing with age) and geographical location [1 4]. There is also evidence that the incidence is higher in urban populations and in areas with high social deprivation [3,5]. These variations have significant implications for haemodialysis capacity and nephrology workforce planning, particularly as the English national service framework for renal services (24) clearly recommends that RRT services should be available to all who can benefit [6]. The UK Renal Registry, which provides data on the current dialysis population, conducted a National Renal Review in 22 that showed a steady increase in incidence rates in England from 67 pmp in 1991 to 98 pmp in 22 [7]. In 22 the Renal Association suggested planning assumptions for acceptance rates onto RRT of pmp [8]. However, the data used for estimating the need for RRT in ethnic populations come from an analysis of data from [9]. Since then, there has been a substantial increase in incidence rates in the total population with increasing numbers of elderly patients commenced on dialysis [3]. There is an urgent need to review age-specific incidence rates in different ethnic populations. Although the Birmingham Health Authority (BHA) ceased to be a functional NHS administrative unit in the reorganizations of 22, it is a distinct geopolitical unit that clearly defines a main industrial part of the West Midlands with a substantial ethnic minority population and a high level of social deprivation. Data from the 1991 and 21 censuses are available to define the population and ethnic mix of the BHA area. There are no published data C The Author [28]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please journals.permissions@oxfordjournals.org
2 3984 M. Lambie et al. Table 1. Ethnicity coding 12 Study 1991 census 21 census White White White: British White: Irish White: Other Black Black African Black or Black British: Caribbean Black Caribbean Black or Black British: African Black Other Black or Black British: Other Mixed: White and Black African Mixed: White and Black Caribbean Indo-Asian Indian Asian or Asian British: Indian Other Bangladeshi Pakistani Other groups: Asian Other groups: Other Chinese Asian or Asian British: Bangladeshi Asian or Asian British: Pakistani Asian or Asian British: Other Asian Mixed: White and Asian Mixed: Other Mixed Chinese and other ethnic groups: Chinese Chinese and other ethnic groups: Other ethnic group regarding current or historical incidence rates for the BHA population. Two renal units provide dialysis for all patients living in this area, there is little cross-boundary flow and both have complete computerized records dating back to 199. By correlating the numbers of incident RRT patients from the BHA area with the populations recorded in the 1991 and 21 censuses, we were able to investigate the associations between ethnicity and age on RRT incidence rates between 199 and 24. Methods We identified all new RRT patients over 16 years of age accepted by both units (Birmingham Heartlands and Queen Elizabeth Hospitals) from 1 January 199 to 31 December 23. We excluded patients who were already on dialysis and transferred in from other areas, transfers from the paediatric unit, non-residents, failed transplants and patients requiring dialysis during a holiday in the area. Patients with acute renal failure were excluded unless they failed to recover function, or if they died within 9 days. The date they were deemed to have irreversible renal failure and thus were regarded as having ESRF was determined by the clinicians at the time and was routinely recorded on the computerized record. We included patients who received a pre-emptive transplant prior to starting on dialysis. Although the surrounding dialysis units are a substantial distance away from the BHA area and cross-boundary migration was likely to be minimal, nearby units were contacted to identify any BHA patients accepted for dialysis during this period. None were identified. The ethnicity was ascertained by clinicians in both units as White (W), Black (B), Indo-Asian (I) and Other (O) and we kept this classification in the analysis. The Office of National Statistics provided the populations for the BHA area from both the 1991 and 21 censuses, along with a breakdown by age and ethnicity. The coding for ethnicity between censuses was different, but we re-coded them into W, B, I and O as shown in Table 1. As the O group was Number of incident patients Fig. 1. Incident RRT population Black Indo-Asian White small, these patients were only included in the analyses for the total population. The age bands were derived by splitting the dialysis population into approximate thirds and rounding into convenient groups (16 54, 55 7, >7 years). The incidence rates were calculated for two cohorts comprising those patients starting dialysis between 199 and 1995 and between 1999 and 24. These dates were chosen to cross the 1991 and 21 census dates. We chose to examine data averaged over 5-year periods to eliminate year-onyear variation and improve the precision of the estimates. Confidence intervals were obtained from Geigy Scientific Tables, based on the Poisson distribution. Statistical analysis was performed using the commercially available SPSS v1 statistical software package. Results A total of 181 new ESRF patients started RRT between 199 and 24. The ethnic breakdown of numbers of new patients starting each year is shown in Figure 1. There was an increase in the numbers of patients starting RRT in all ethnic groups throughout the study period. The change in the Birmingham population between the 1991 and 21 censuses is shown in Figure 2. The total population remained similar (966,41 in 1991 versus 977,99 in 21) but the ethnic mix changed with W falling from 78.5% to 7% whilst I and B increased from 13.5% to 2% and 5.9% to 7.9%, respectively. The annualized RRT incidence rates for the two time periods are shown in Table 2. There was a consistent increase of 4% in all ethnic groups between the 1991 and 21 cohorts. However, the incidence rate for the total population increased by 55%. This is because the B and I populations which had much higher incidence rates constituted a greater proportion of the total population in 21 (27.9%) than in 1991 (19.4%, Figure 2). In , the incidence rate for I was 1.88 and for B was 2.16 times greater than W. Similar proportional differences (I, 1.87 and B, 2.15) were seen in Changes in the mean age of the incident RRT patients of different ethnic groups over the last 14 years are shown
3 Ethnicity, age and incidence rates for RRT in Birmingham black 25 1 indoasian white Population number Percentage change >7 2 Fig. 2. Birmingham demographics. Table 2. Annualized RRT incidence rates a a % change Total 17 (99 118) 166 ( ) +55 White 92 (83 13) 129 (116 14) +4 Indo-Asian 175 (139 24) 243 ( ) +39 Black 191 ( ) 278 ( ) +46 a 95% confidence intervals are shown in parentheses. Mean age Black White Indo-Asian Fig. 3. Mean average age of incident RRT patients in Figure 3. W was always the oldest, but the mean age of incident RRT patients in all ethnic groups increased. The proportional changes in the age profiles of the different ethnic groups between 1991 and 21 are shown in Figure 4. The population decreased in all age groups for W but the fall was smallest in the >7s. Thus, the median age increased from 45.1 to 45.9 years. Numbers of I increased in all age groups but proportionally much more in the >7s (1864 to 5844, %). However, the smaller percentage increase in numbers in the younger groups ( to in the 16 54s, +65%) occurred in a proportionately much larger young population so the median age fell from 33.5 to 32.9 years. For B, there was a similar percentage increase -5 White Indo-Asian Black Fig. 4. Changes in age profile of Birmingham population from 1991 to 21. Annualised incidence rate pmp >7 White IA Black White IA Black Fig. 5. Annualized incidence rates for RRT by age and ethnicity. in the >7s (1327 to 3874, +192%), but the increase in the younger groups was less than for I and the median age increased from 33.5 to 37.5 years. Annualized RRT incidence rates for the different age and ethnic groups are shown in Figure 5. There was little change in the incidence rates in 16 54s for all three ethnic groups between the 1991 and 21 cohorts, and in the White 55 7 age group ( pmp). There was a significant increase in B ( pmp) and I ( pmp) in the 55 7 age group. The biggest differences were seen in the >7 s. For W, the increase was 248% ( pmp), for I 319% ( pmp) and for B 617% ( pmp). Discussion The National Renal Review in 22 [3] reported an incidence rate for RRT of 98 pmp for England, 118 pmp for Wales and 12 pmp for Scotland. The rate reported for the West Midlands was 113 pmp. The BHA incidence rates of 166 pmp for reported in this study are comparable with the highest reported in the UK to date. Other areas
4 3986 M. Lambie et al. with high incidence rates in 22 [3] include Wolverhampton (169 pmp) and Ealing Hammersmith and Hounslow (17 pmp). Birmingham s incidence rate has been consistently high, being 17 pmp in compared with the rate for England of 82 pmp in [9]. From to incidence rates for the different ethnic populations in Birmingham rose by 39 46%. This is similar in proportion to the increase in the English incidence rates of 46% between 1991 and 22 (67 98 pmp). Most of the increase is due to a greatly increased incidence in the elderly (Figure 5). The lack of change in incidence rates in all younger Birmingham populations suggests that there was no unmet need for RRT. Previous UK studies examining incidence rates in agespecific ethnic groups include Roderick et al. on data from [9], where rates were estimated for the whole of England, and Higgins et al. [1], where rates were estimated for the Coventry population, a region similar to the one in this study. Our results were similar to, or higher than, both studies in all ethnic groups and most age groups. The incidence rates described in this study are reliable as we studied a large number of patients with a complete record of age and ethnicity over a prolonged period of time. One of the common problems affecting calculation of incidence rates is cross-boundary flow, particularly in large urban areas. This was not a problem in our study as the surrounding units are a significant distance away and we confirmed that no patients from BHA were accepted by adjacent units. There are several possible reasons for Birmingham s high incidence rates. These include the large ethnic populations, poor primary care provision, social deprivation, comparatively easy access to renal services and physician practice. Furthermore, census underenumeration may also contribute, although this occurs mainly in younger Blacks and so is unlikely to be important to our data. Unfortunately, we did not have sufficiently complete data on aetiology of ESRF from our databases to analyse this issue further. Clinicians practising over the time span of the study did not feel that access to dialysis services had limited ESRF take on rates at any point. Black and Indo-Asian ethnicity is associated with higher incidence rates [2,9] and Birmingham has a large ethnic population (28% B or I in 21). We confirmed that the incidence rate for the combined ethnic minorities was high, with relative risks between 2.6 and 5.5 compared to Whites, depending on age. This is not the sole explanation for the high overall incidence rate for RRT in Birmingham as the rate of 129 pmp for the W population was still higher than the national rate. A variety of explanations for the excess risk of ESRF experienced by I and B populations have been proposed. It is well recognized that B and I have a higher prevalence of non-insulin-dependent diabetes mellitus and B in particular have a high prevalence of hypertension [11]. However, there is now good evidence that this, along with other environmental and social factors, does not completely explain the increased risk of ESRF. White diabetics are at greater risk of MI, congestive heart failure, stroke and lower extremity amputation than other diabetic populations but are at a significantly lower risk of ESRF [12]. Indo-Asian diabetics in Leicestershire were found to be 13 times more likely to develop ESRF than White diabetics [13]. Several large observational studies have shown that, even after correcting for factors such as diabetes, hypertension, access to care and social deprivation, there is a significant unexplained relative risk of ESRF [14 18] in ethnic minority populations. Using data from the third National Health and Nutrition Examination Survey (NHANES) and the United States Renal Data System, Hsu et al. demonstrated a greater rate of progression from CRF to ESRF [19] in African Americans, consistent with the finding of a similar prevalence of CRF in African Americans and American Whites in NHANES [2]. Ethnic minorities, particularly those with an estimated glomerular filtration rate of <6 ml/min, are also at higher risk of proteinuria, a known risk factor for CKD progression, irrespective of diabetes [21]. One hypothesis to explain this predisposition is the higher incidence of low birth weight among African Americans. Low birth weight has been shown to correlate with the number of glomeruli in the adult kidney (although ethnicity alone had no effect on nephron mass) [22] and also to the subsequent risk of ESRF, particularly during the first 14 years of life [23], as well as chronic kidney disease [24]. Genetic susceptibility is another possibility. A family history of ESRF is associated with a three- to nine-fold increase in the risk of developing nephropathy in African Americans [25,26]. Several different causes of ESRF, including types I and II diabetes mellitus, hypertension, HIV and lupus nephritis are associated with familial clustering [26,27]. Candidate loci for nephropathy susceptibility genes have been identified in different ethnic groups on chromosomes 3q, 1q and 18q [26,28 3] and linkage between African American ESRF and the locus for plasma kallikrein has also been demonstrated [31]. Less information is available on possible reasons for excess risk in Indo-Asians, although two studies did suggest idiopathic interstitial nephritis as well as focal, segmental glomerulosclerosis, chronic pyelonephritis and systemic lupus erythematosus were over-represented in this group [4,32]. UK studies have demonstrated a significant correlation between the incidence/prevalence of RRT and social deprivation [5,33]. Large studies in Australia, New Zealand and the USA have also demonstrated this link [17,34]. The effect of deprivation is complicated by the association this has with ethnicity. The UK Renal Registry published data in 23 showing a clear association between deprivation and ethnicity [3]. Multiple regression analysis found no correlation between social deprivation and incidence rates for RRT after correcting for ethnicity, although a further analysis (not published) excluding areas of high ethnicity did demonstrate a significant correlation. Geographical proximity to renal services has been shown to increase RRT incidence rates [5]. This may be relevant in Birmingham, a relatively small densely populated area with good internal transport links, although a recent study suggested that rural populations in the USA have a higher incidence of ESRF [35]. We have demonstrated much higher RRT incidence rates in all Birmingham populations compared to the rest of the
5 Ethnicity, age and incidence rates for RRT in Birmingham 3987 UK but particularly in older people from ethnic minority groups. As anticipated from trends in immigration, the Black population in Birmingham aged during our study and is predicted to age further. The Indo-Asian population is younger, larger and likely to follow this trend. This applies for ethnic minority populations in other areas of the UK. This combination has significant implications for the future supply of RRT in similar areas within the UK and other countries, and the need for chronic kidney disease prevention. Conflict of interest statement. Dr Nick Richards is now Medical Director of Fresenius Medical Renal Services but was Medical Director of the Renal Unit, Queen Elizabeth Hospital, for the duration of the study. There is no conflict of interest for the other authors. The results presented in this paper have not been published previously in whole or part, except in abstract format. References 1. Roderick PJ, Jones I, Raleigh VS et al. Population need for renal replacement therapy in Thames regions: ethnic dimension. BMJ 1994; 39: US Renal Data System. USRDS 23 Annual Data Report: Atlas of End Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, Ansell D, Feest TG, Byrne C et al. UK Renal Registry Report 23. UK Renal Registry, Bristol, Lightstone L, Rees AJ, Tomson C et al. High incidence of end-stage renal disease in Indo-Asians in the UK. QJMed1995; 88: Roderick P, Clements S, Stone N et al. What determines geographical variation in rates of acceptance onto renal replacement therapy in England? J Health Serv Res Policy 1999; 4: The National Service Framework for Renal Services. Part I: Dialysis and Transplantation. London: Department of Health, Ansell D, Feest TG, Byrne C et al. National Renal Review 22: Summary Report on Adult and Paediatric Renal Services. UK Renal Registry, Bristol, Treatment of adults and children with renal failure: standards and audit measures. Royal College of Physicians of London and the Renal Association, London, Roderick PJ, Raleigh VS, Hallam L et al. The need and demand for renal replacement therapy in ethnic minorities in England. J Epidemiol Community Health 1996; 5: Higgins RM, Edmunds ME, Dukes DC. End-stage renal failure in Indo-Asians. QJMed1995; 88: Brancati FL, Kao WH, Folsom AR et al. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2; 283: Karter AJ, Ferrara A, Liu JY et al. Ethnic disparities in diabetic complications in an insured population. JAMA 22;287: Burden AC, McNally PG, Feehally J et al. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet Med 1992; 9: Klag MJ, Whelton PK, Randall BL et al. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997; 277: Brancati FL, Whittle JC, Whelton PK et al. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA 1992; 268: Tarver-Carr ME, Powe NR, Eberhardt MS et al. Excess risk of chronic kidney disease among African American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol 22; 13: Byrne C, Nedelman J, Luke RG. Race, socioeconomic status, and the development of end-stage renal disease. AmJKidneyDis1994; 23: McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 1988; 12: Hsu CY, Lin F, Vittinghoff E et al. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 23; 14: Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 23; 41: Bryson CL, Ross HJ, Boyko EJ et al. Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. Am J Kidney Dis 26; 48: Hughson M, Farris AB, 3rd, Douglas-Denton R et al. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 23; 63: Vikse BE, Irgens LM, Leivestad T et al. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol 28;19: Fan ZJ, Lackland DT, Lipsitz SR et al. The association of low birthweight and chronic renal failure among Medicaid young adults with diabetes and/or hypertension. Public Health Rep 26; 121: Freedman BI, Spray BJ, Tuttle AB et al. The familial risk of endstage renal disease in African Americans. AmJKidneyDis1993; 21: Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal disease. Kidney Int Suppl 25; 67: S46 S Freedman BI, Wilson CH, Spray BJ et al. Familial clustering of endstage renal disease in blacks with lupus nephritis. AmJKidneyDis 1997; 29: Bowden DW, Colicigno CJ, Langefeld CD et al. A genome scan for diabetic nephropathy in African Americans. Kidney Int 24; 66: Freedman BI, Rich SS, Yu H et al. Linkage heterogeneity of endstage renal disease on human chromosome 1. Kidney Int 22; 62: Moczulski DK, Rogus JJ, Antonellis A et al. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 1998; 47: Yu H, Bowden DW, Spray BJ et al. Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in endstage renal disease. Hypertension 1998; 31: Ball S, Lloyd J, Cairns T et al. Why is there so much end-stage renal failure of undetermined cause in UK Indo-Asians? QJM 21; 94: Maheswaran R, Payne N, Meechan D et al. Socioeconomic deprivation, travel distance, and renal replacement therapy in the Trent Region, United Kingdom 2: an ecological study. J Epidemiol Community Health 23; 57: Cass A, Cunningham J, Wang Z et al. Social disadvantage and variation in the incidence of end-stage renal disease in Australian capital cities. Aust N Z J Public Health 21; 25: Fan ZJ, Lackland DT, Lipsitz SR et al. Geographical patterns of endstage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health Place 27; 13: Received for publication: Accepted in revised form: 9.6.8
. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less
Chapter 5: Joint Analyses with UK Transplant in England and Wales; Access to the Renal Transplant Waiting List, Time to Listing, Diabetic Access to Transplantation and the Influence of Social Deprivation
More informationChronic kidney disease (CKD) is a complex
IN THE LITERATURE The Genetic Basis of Kidney Disease Risk in African Americans: MYH9 as a New Candidate Gene Commentary on Kopp JB, Smith MW, Nelson GW, et al: MYH9 is a major-effect risk gene for focal
More informationTransplant Activity in the UK
Transplant Activity in the UK 2006-2007 This document has been produced by the Statistics and Audit Directorate. UK Transplant August 2007 Cover pictures: Members of Glamorgan County cricket team help
More informationChapter 6: Predicting Future Demand in England, a Simulation Model of Renal Replacement Therapy
Chapter 6: Predicting Future Demand in England, a Simulation Model of Renal Replacement Therapy Dr Paul Roderick, Senior Lecturer in Public Health Medicine, Southampton University Dr Ruth Davies, Senior
More informationLong-term outcomes in nondiabetic chronic kidney disease
original article http://www.kidney-international.org & 28 International Society of Nephrology Long-term outcomes in nondiabetic chronic kidney disease V Menon 1, X Wang 2, MJ Sarnak 1, LH Hunsicker 3,
More informationDOWNLOAD PDF KIDNEY DISEASES IN THE DEVELOPING WORLD AND ETHNIC MINORITIES
Chapter 1 : The burden of chronic kidney disease Kidney Diseases in the Developing World and Ethnic Minorities is a chapter, page book describing the epidemiological, organizational, and financial challenges
More informationChapter 2: Identification and Care of Patients With Chronic Kidney Disease
Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets
More informationThe varying influence of socioeconomic deprivation on breast cancer screening uptake in London
Journal of Public Health Vol. 38, No. 2, pp. 330 334 doi:10.1093/pubmed/fdv038 Advance Access Publication March 31, 2015 The varying influence of socioeconomic deprivation on breast cancer screening uptake
More informationChapter 3: National Renal Review 2002: summary report on adult and paediatric renal services
Chapter 3: National Renal Review : summary report on adult and paediatric renal services Summary The total annual acceptance rate of new patients for Renal Replacement Therapy (RRT) in the UK was 103.0
More informationTRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA
& TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA 2002-2008 Halima Resić* 1, Enisa Mešić 2 1 Clinic for Hemodialysis, University of Sarajevo Clinics Centre, Bolnička 25, 71000 Sarajevo, Bosnia
More informationRegional differences in the provision of adult renal dialysis services in the UK
Q J Med 2005; 98:183 190 doi:10.1093/qjmed/hci023 Original papers Regional differences in the provision of adult renal dialysis services in the UK L. BLANK 1, J. PETERS 1, A. LUMSDON 2, D.J. O DONOGHUE
More informationThe timing of dialysis initiation affects the incidence of renal replacement therapy Cécile Couchoud appliquées Paris 5
The timing of dialysis initiation affects the incidence of renal replacement therapy Cécile Couchoud appliquées Paris * REIN Registry Agence de la biomé decine CNRS : UMR814, Universit é Paris Descartes
More informationEffect of Community Characteristics on Familial Clustering of End-Stage Renal Disease
Original Report: Patient-Oriented, Translational Research American Journal of Nephrology DOI: 10.1159/000243716 Received: July 15, 2009 Accepted: August 30, 2009 Published online: September 30, 2009 Effect
More informationUK Renal Registry 20th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2016
Nephron 2018;139(suppl1):105 116 DOI: 10.1159/000490962 Published online: July 11, 2018 UK Renal Registry 20th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population
More informationChapter 3: Morbidity and Mortality in Patients with CKD
Chapter 3: Morbidity and Mortality in Patients with CKD In this 2017 Annual Data Report (ADR) we introduce analysis of a new dataset. To provide a more comprehensive examination of morbidity patterns,
More informationOrgan Donation and Transplantation data for Black, Asian and Minority Ethnic (BAME) communities. Report for 2015/2016 (1 April March 2016)
Organ Donation and Transplantation data for Black, Asian and Minority Ethnic (BAME) communities Report for 2015/2016 (1 April 2010 31 March 2016) INTRODUCTION This report provides information related to
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease
More informationDownloaded from:
Iwagami, M; Tomlinson, LA; Mansfield, KE; Casula, A; Caskey, FJ; Aitken, G; Fraser, SD; Roderick, PJ; Nitsch, D (2017) Validity of estimated prevalence of decreased kidney function and renal replacement
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More informationOrgan Donation and Transplantation data for Black, Asian and Minority Ethnic (BAME) communities. Report for 2016/2017 (1 April March 2017)
Organ Donation and Transplantation data for Black, Asian and Minority Ethnic (BAME) communities Report for 6/7 ( April March 7) CONTENTS EXECUTIVE SUMMARY... INTRODUCTION... ORGAN DONOR REGISTER (ODR)...
More informationDisparities in Transplantation Caution: Life is not fair.
Disparities in Transplantation Caution: Life is not fair. Tuesday October 30 th 2018 Caroline Rochon, MD, FACS Surgical Director, Kidney Transplant Program Hartford Hospital, Connecticut Outline Differences
More informationChapter 6: Medicare Expenditures for CKD
Chapter 6: Medicare Expenditures for CKD Introduction Determining the economic impact of chronic kidney disease (CKD) on the health care system is challenging on several levels. There is, for instance,
More informationOrgan Donation and Transplantation data for Black, Asian and Minority Ethnic (BAME) communities. Report for 2017/2018 (1 April March 2018)
Organ Donation and Transplantation data for Black, Asian and Minority Ethnic (BAME) communities Report for 07/0 ( April 0 March 0) CONTENTS EXECUTIVE SUMMARY... INTRODUCTION... ORGAN DONOR REGISTER (ODR)...
More informationCHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand
CHAPTER 9 End Stage Kidney Disease in Aotearoa/New Zealand ANZDATA gratefully acknowledges the patients and their families and the clinicians who provided data, and the contributions of the Aotearoa/New
More informationAn epidemic of chronic kidney disease: fact or fiction?
Nephrol Dial Transplant (2008) 23: 1117 1121 doi: 10.1093/ndt/gfn086 Debate on the epidemic of chronic kidney disease The Challenge An epidemic of chronic kidney disease: fact or fiction? Richard J. Glassock
More informationThe number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033
5 Kidney Activity Kidney Activity Key messages The number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033 The number of deceased kidney donors increased by
More informationAcceptance onto dialysis guidelines: St George Hospital
Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines
More informationNational Child Measurement Programme Changes in children s body mass index between 2006/07 and 2010/11
National Child Measurement Programme Changes in children s body mass index between 2006/07 and 2010/11 Delivered by NOO on behalf of the Public Health Observatories in England Published: March 2012 NOO
More informationThe number of patients on the active liver transplant list at 31 March 2017 was 530, a fall of 8% from 2016
8 Liver Activity Liver Activity Key messages The number of patients on the active liver transplant list at 31 March 2017 was 530, a fall of 8% from 2016 The number of liver donors after brain death increased
More informationCardiovascular disease profile
Cardiovascular disease profile Kidney disease Background This chapter of the Cardiovascular disease profiles focuses on kidney disease and is produced by the National Cardiovascular Intelligence Network
More informationThe number of patients registered on the kidney transplant list this year fell by 7% from 5686 to 5275
5 Kidney Activity Kidney Activity Key messages The number of patients registered on the kidney transplant list this year fell by 7% from 5686 to 5275 The number of deceased kidney donors increased by 7%
More informationTRANSPLANT ACTIVITY IN THE UK
Activity Report 2010/11 TRANSPLANT ACTIVITY IN THE UK www.nhsbt.nhs.uk PREFACE This report has been produced by Statistics and Clinical Audit, NHS Blood and Transplant. All figures quoted in this report
More informationThe 15 th Emerging New Researchers in the Geography of Health and Impairment Conference June Paris France
The 15 th Emerging New Researchers in the Geography of Health and Impairment Conference 10-11 June 2010 -Paris France http://www.irdes.fr/enrghi2010 enrghi2010@irdes.fr Overview Chronic kidney disease
More informationCharacteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data
DIALYSIS Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 7 to 14 Analysis From Henan Peritoneal Dialysis Registry data Xiaoxue Zhang, 1 Ying Chen, 1,2 Yamei Cai, 1 Xing Tian,
More informationPrevalence of chronic renal failure in adults in Delhi, India
Nephrol Dial Transplant (2005) 20: 1638 1642 doi:10.1093/ndt/gfh855 Advance Access publication 26 April 2005 Original Article Prevalence of chronic renal failure in adults in Delhi, India Sanjay Kumar
More informationSpecial Challenges and Co-Morbidities
Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine
More informationBurden of end-stage renal disease
Summary of Indigenous health: End-stage renal disease Neil Thomson and Sasha Stumpers Australian Indigenous HealthInfoNet, Edith Cowan University www.healthinfonet.ecu.edu.au This summary of end-stage
More informationNational Audit of CKD in Primary Care
National Audit of CKD in Primary Care David C Wheeler Royal Free Campus University College London d.wheeler@ucl.ac.uk Kidney for General Physicians RCP London 24 th November 2017 Who looks after CKD patients
More informationThe Health Problem: Guidelines: NHS Priority:
PRIORITY BRIEFING The purpose of this briefing paper is to aid Stakeholders in prioritising topics to be taken further by PenCLAHRC as the basis for a specific evaluation or implementation research project.
More informationTREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009
TREAT THE KIDNEY TO SAVE THE HEART Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 1 ESRD Prevalent Rates in 1996 per million population December
More informationChapter 1: Incidence, Prevalence, Patient Characteristics, and Treatment Modalities
Chapter 1: Incidence, Prevalence, Patient Characteristics, and Treatment Modalities INCIDENCE In 2015, there were 124,114 newly reported cases of ESRD; the unadjusted (crude) incidence rate was 378 per
More informationChapter 3: Morbidity and Mortality
Chapter 3: Morbidity and Mortality Introduction In this chapter we evaluate the morbidity and mortality of chronic kidney disease (CKD) patients continuously enrolled in Medicare. Each year s analysis
More informationNational Surveillance System for Dialysis Centre and Dialysis Associated Diseases
National Surveillance System for Dialysis Centre and Dialysis Associated Diseases Dr Richard Fluck Consultant Renal Physician & Clinical Director, Royal Derby Hospital UK RA Vascular Access Survey 2005
More informationDialysis Mortality Regional Clinical Audit Report 2011
Dialysis Mortality Regional Clinical Audit Report 2011 Clinical Audit Lead: Authors: Dr Iren Szeki Consultant Nephrologist, Manchester Royal Infirmary Dr Iren Szeki, Consultant Nephrologist Dr Helen Alderson,
More informationThe incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivation
clinical investigation http://www.kidney-international.org & 2013 International Society of Nephrology The incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivation
More informationNational Diabetes Audit, Report 2a: Complications and Mortality (complications of diabetes) England and Wales 13 July 2017
National Diabetes Audit, 2015-16 Report 2a: Complications and Mortality (complications of diabetes) 13 July 2017 V0.22 7 March 2017 Prepared in collaboration with: The Healthcare Quality Improvement Partnership
More informationUdaya Udayaraj a, Rishi Pruthi b, Anna Casula b, Paul Roderick c
UK Renal Registry 16th Annual Report: Chapter 6 Demographics and Outcomes of Patients from Different Ethnic Groups on Renal Replacement Therapy in the UK Udaya Udayaraj a, Rishi Pruthi b, Anna Casula b,
More informationSHORT COMMUNICATION. G. Joshy & P. Dunn & M. Fisher & R. Lawrenson
Diabetologia (2009) 52:1474 1478 DOI 10.1007/s00125-009-1380-1 SHORT COMMUNICATION Ethnic differences in the natural progression of nephropathy among diabetes patients in New Zealand: hospital admission
More informationChronic Kidney Disease
Chronic Kidney Disease Chronic Kidney Disease (CKD) Educational Objectives Outline Demographics Propose Strategies to slow progression and improve outcomes Plan for treatment of CKD Chronic Kidney Disease
More informationSocial deprivation, ethnicity and access to kidney transplantation in England and Wales. Udaya Udayaraj
Social deprivation, ethnicity and access to kidney transplantation in England and Wales Udaya Udayaraj Introduction (1) Kidney transplantation Improved survival compared to remaining on dialysis Better
More informationC aring for patients with interstitial lung disease is an
980 INTERSTITIAL LUNG DISEASE Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK J Gribbin, R B Hubbard, I Le Jeune, C J P Smith, J West, L J Tata... See end of article
More informationUniversity of Groningen. C-reactive protein and albuminuria Stuveling, Erik Marcel
University of Groningen C-reactive protein and albuminuria Stuveling, Erik Marcel IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationChapter IV. Incidence and Causes of Treated ESRD. Methods
Annual Data Report Chapter IV Incidence and Causes of Treated ESRD T he statistics in this chapter show a continued increase in the annual incidence rate of newly treated ESRD in the United States. The
More informationSoo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital
Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital Agenda Association between Cardiovascular Disease and Type 2 Diabetes Importance of HbA1c Management esp. High risk patients
More informationNarender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
More informationChapter 2: Identification and Care of Patients With CKD
Chapter 2: Identification and Care of Patients With CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease
More informationJ Am Soc Nephrol 14: , 2003
J Am Soc Nephrol 14: 1568 1577, 2003 The Contribution of Increased Diabetes Prevalence and Improved Myocardial Infarction and Stroke Survival to the Increase in Treated End-Stage Renal Disease PAUL MUNTNER,*
More informationChapter 10: Dialysis Providers
Chapter 10: Dialysis Providers In 2014 the two largest dialysis organizations, Fresenius and DaVita, collectively treated 69% of patients in 65% of all dialysis units (Figure 10.2). Nearly 90% of all dialysis
More informationDiabetes and renal disease: who does what?
CLINICAL PRACTICE Clinical Medicine 2013, Vol 13, No 5: 460 4 Diabetes and renal disease: who does what? Ruth K Jones, David Hampton, Daniel J O Sullivan and Aled O Phillips ABSTRACT Care of patients with
More informationTransplant Inequalities A United Kingdom Perspective
1 Transplant Inequalities A United Kingdom Perspective Gurch Randhawa Institute for Health Research, University of Bedfordshire, UK 1. Introduction The UK s Organ Donation Taskforce brought policy and
More informationInternational IBD Genetics Consortium
International IBD Genetics Consortium PRED4 Proton Pump Inhibitor Induced Nephritis Case Report FormS Please stick study label here On completion, please return to: IBD Pharmacogenetics Research Office
More informationChapter 15: Causes of Death on Renal Replacement Therapy
Chapter 15: Causes of Death on Renal Replacement Therapy Summary Cardiovascular disease is the most common cause of death in the renal population and is most evident in diabetics. Patients on renal replacement
More informationNational Chronic Kidney Disease Audit
National Chronic Kidney Disease Audit // National Report: Part 2 December 2017 Commissioned by: Delivered by: // Foreword by Fiona Loud And if, as part of good, patient-centred care, a record of your condition(s),
More informationChronic kidney disease in African Americans: Puzzle pieces are falling into place
ADDRESSING DISPARITIES IN HEALTHCARE LEARNING OBJECTIVE: Readers will recognize recent advances in the understanding of chronic kidney disease in African Americans JOSEPH V. NALLY, JR, MD Former Director,
More informationDialysis Initiation and Optimal Vascular Access: Outcomes and Mortality
Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. 5. Classification of chronic kidney disease based on evaluation of kidney function
5. Classification of chronic kidney disease based on evaluation of kidney function Date written: April 2005 Final submission: May 2005 GUIDELINES No recommendations possible based on Level I or II evidence
More informationDialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5
Nephrol Dial Transplant (2007) 22: 1955 1962 doi:10.1093/ndt/gfm153 Advance Access publication 4 April 2007 Original Article Dialysis or not? A comparative survival study of patients over 75 years with
More informationManagement of End Stage Renal Disease-Bangladesh Perspective
Send Orders for Reprints to reprints@benthamscience.net 108 The Open Urology & Nephrology Journal, 2014, 7, 108-112 Management of End Stage Renal Disease-Bangladesh Perspective Harun Ur Rashid * Open Access
More informationCHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2007
CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 27 Stephen McDonald Leonie Excell Hannah Dent NEW PATIENTS ANZDATA Registry 28 Report Figure 2.1 Annual Intake of New Patients 23-27 (Number Per Million Population)
More informationChapter 1: Incidence, Prevalence, Patient Characteristics, and Treatment Modalities
Chapter 1: Incidence, Prevalence, Patient Characteristics, and Treatment Modalities INCIDENCE In 2016, there were 124,675 newly reported cases of ESRD; the unadjusted (crude) incidence rate was 373.4 per
More information2017 USRDS ANNUAL DATA REPORT KIDNEY DISEASE IN THE UNITED STATES S611
Healthy People 2020 In this chapter, we examine data for 11 Healthy People 2020 (HP2020) objectives 10 for CKD and one for diabetes spanning 20 total indicators for which the USRDS serves as the official
More informationChronic Kidney Disease Prevalence and Rate of Diagnosis
The American Journal of Medicine (2007) 120, 981-986 CLINICAL RESEARCH STUDY Chronic Kidney Disease Prevalence and Rate of Diagnosis Timothy P. Ryan, PhD, a James A. Sloand, MD, b Paul C. Winters, MS,
More informationAn epidemic of renal failure among Australian Aboriginals
emja Australia The Medical Journal of Home Issues emja shop Classifieds Contact More... Topics Search Login Buy full access An epidemic of renal failure among Australian Aboriginals Janine L Spencer, Desiree
More informationThe number of patients waiting on the pancreas transplant list fell by 1% during the year, to 224 at 31 March 2017
6 Pancreas Activity Pancreas Activity Key messages The number of patients waiting on the pancreas transplant list fell by 1% during the year, to 224 at 31 March 2017 The number of pancreas donors after
More informationChapter 2: Identification and Care of Patients with CKD
Chapter 2: Identification and Care of Patients with CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease
More informationThis report has been produced by Statistics and Clinical Audit, NHS Blood and Transplant.
Preface This report has been produced by Statistics and Clinical Audit, NHS Blood and Transplant. All figures quoted in this report are as reported to NHS Blood and Transplant by 20 May 2013 for the UK
More informationHow the UK Renal Registry has improved the lives of renal patients
How the UK Renal Registry has improved the lives of renal patients [is improving and will improve] Dr Fergus Caskey Medical Director of the UK Renal Registry NKF Annual Conference, Reading, 10th October
More informationNational Diabetes Audit
National Diabetes Audit Executive Summary Key findings about the quality of care for people with diabetes in England and Wales Report for the audit period 2007-2008 Prepared in partnership with: Executive
More informationRESEARCH. Variation between centres in access to renal transplantation in UK: longitudinal cohort study
Variation between centres in access to renal transplantation in UK: longitudinal cohort study R Ravanan, consultant nephrologist, 1 U Udayaraj, consultant nephrologist, 1 D Ansell, director, 2 D Collett,
More informationChapter 1: CKD in the General Population
Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table
More informationIntroduction. 1. Introduction
1. Introduction Chronic kidney disease (CKD) encompasses a spectrum of different pathophysiologic processes associated with abnormal kidney function, and a progressive decline in glomerular filtration
More informationChapter 2: Identification and Care of Patients With CKD
Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,
More informationDr Michael Rayment Chelsea and Westminster Hospital, London
17 TH ANNUAL CONFERENCE OF THE BRITISH HIV ASSOCIATION (BHIVA) Dr Michael Rayment Chelsea and Westminster Hospital, London 6-8 April 2011, Bournemouth International Centre A decade of renal biopsies in
More informationRESEARCH. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore
Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore Julia Hippisley-Cox, professor of clinical epidemiology and general practice, 1 Carol Coupland,
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 6: Medicare Expenditures for Persons With CKD Medicare spending for patients with CKD aged 65 and older exceeded $50 billion in 2013, representing 20% of all
More informationORIGINAL REPORTS: PATHOPHYSIOLOGY
ORIGINAL REPORTS: PATHOPHYSIOLOGY RENAL DISEASE: ENVIRONMENT, RACE, OR GENES? Diabetic nephropathy is over-represented in people of color. This reflects both environmental and genetic factors. Numerous
More informationChapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report
Chapter 12 End Stage Kidney Disease in Indigenous Peoples of and Aotearoa/ 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, the rates and practice patterns for end-stage
More informationLow Birth Weight Increases Risk for End-Stage Renal Disease
JASN Express. Published on December 5, 2007 as doi: 10.1681/ASN.2007020252 Low Birth Weight Increases Risk for End-Stage Renal Disease Bjørn Egil Vikse,* Lorentz M. Irgens, Torbjørn Leivestad, Stein Hallan,
More informationThe number of patients waiting on the pancreas transplant list fell by 7% during the year, to 252 at 31 March 2015
6 Pancreas Activity Pancreas Activity Key messages The number of patients waiting on the pancreas transplant list fell by 7% during the year, to 252 at 31 March 2015 The number of pancreas donors after
More informationSubstance misuse among young people The data for
Substance misuse among young people The data for 28-9 EFFECTIVE TREATMENT CHANGING LIVES www.nta.nhs.uk Substance misuse among young people The data for 28-9 More teenagers are receiving help for drug
More informationCommunity-based incidence of acute renal failure
original article http://www.kidney-international.org & 2007 International Society of Nephrology Community-based incidence of acute renal failure C-y Hsu 1, CE McCulloch 2, D Fan 3, JD Ordoñez 4, GM Chertow
More informationATRIAL FIBRILLATION AND ETHNICITY. Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE)
ATRIAL FIBRILLATION AND ETHNICITY Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE) Atrial fibrillation (AF) and ethnicity The known The unknown The paradox Why
More informationNHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME
NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME INTRODUCTION 1 Three working groups were established to consider whether changes were
More informationChronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009
Chronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009 Minesh Khatri Internal Medicine R2 Background Patients
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic kidney disease: early identification and management of adults with chronic kidney disease in primary and secondary
More informationPopulation-wide Chronic Kidney Disease Management Reducing the Incidence of Kidney Failure
Population-wide Chronic Kidney Disease Management Reducing the Incidence of Kidney Failure Dr Hugh Rayner MD FRCP DipMedEd Consultant Nephrologist Heart of England NHS Foundation Trust hughrayner@nhs.net
More informationAssociation Analysis of the Reticulon 1 Gene in End-Stage Kidney Disease
American Journal of Nephrology Original Report: Patient-Oriented, Translational Research Received: August 26, 2015 Accepted: September 16, 2015 Published online: October 24, 2015 Association Analysis of
More informationSCOTTISH REAL BIOPSY REGISTRY: SURVEY OF NATIVE KIDNEY BIOPSY IN SCOTLAND 2015
Scottish Renal Registry Report SECTION N SCOTTISH REAL BIOPSY REGISTRY: SURVEY OF NATIVE KIDNEY BIOPSY IN SCOTLAND All centres in Scotland were able to provide date of birth, sex (except centre), indication
More informationEPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS KDIGO. Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas
EPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas Disclosure of Interests AstraZeneca (scientific advisory board) Bayer
More informationAcute renal failure: factors influencing nephrology referral and outcome
QJMed 1997; 90:781-785 Acute renal failure: factors influencing nephrology referral and outcome I.H. KHAN, G.R.D. CATTO, N. EDWARD and A.M. MACLEOD From the Department of Medicine and Therapeutics, and
More information